PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
54,236,025
Share change
+2,537,741
Total reported value
$333,006,052
Put/Call ratio
43%
Price per share
$6.14
Number of holders
103
Value change
+$15,386,619
Number of buys
48
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q3 2023

As of 30 Sep 2023, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,236,025 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BlackRock Inc., JPMORGAN CHASE & CO, Boxer Capital, LLC, Avoro Capital Advisors LLC, Euclidean Capital LLC, Verition Fund Management LLC, RTW INVESTMENTS, LP, ALKEON CAPITAL MANAGEMENT LLC, and VANGUARD GROUP INC. This page lists 103 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.